Table 4.
Data | DDX60 expression | Unadjusted (RT vs NRT) | Adjusted (RT vs NRT) | ||
---|---|---|---|---|---|
HR (95% CI) | p values | HR (95% CI) | p values | ||
Training | High (n = 175) | 4.266 (0.943–19.290) | 0.060 | 3.582 (0.627–20.467) | 0.054 |
Low (n = 175) | 0.312 (0.123–0.789) | 0.014 | 0.244 (0.064–0.921) | 0.040 | |
Validation | High (n = 178) | 1.848 (0.520–6.571) | 0.343 | 2.421 (0.460–12.773) | 0.297 |
Low (n = 172) | 0.314 (0.135–0.729) | 0.007 | 0.199 (0.062–0.646) | 0.007 | |
All data | High (n = 353) | 2.831 (1.074–7.461) | 0.035 | 1.687 (0.485–5.866) | 0.411 |
Low (n = 347) | 0.341 (0.186–0.626) | <0.001 | 0.395 (0.186–0.840) | 0.016 |
Note. Adjusted factors: age, history of other malignancies, histologic type, first surgical procedure, TNM stages, ER status, PR status, HER2 status, and chemotherapy.